Procter & Gamble Hosts Global Olympians Justine & Chloe Dufour-Lapointe, Michelle Kwan, Elana Meyers Taylor and Katarzyna Bachleda-Curuś to Discuss Gender Bias
As part of the Olympic Winter Games PyeongChang 2018, Procter & Gamble (NYSE: PG), a Worldwide Olympic Partner, today hosted a panel discussion on gender equality. As part of “Love Over Bias,” the latest installment of P&G’s award-winning “Thank You, Mom” campaign, a panel of decorated female Olympians discussed their own journeys to the global stage. The discussion included the role of their moms, mentorship and support from other women, as well as their hopes for what the current global movement for gender equality will mean for future generations of female athletes.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180213005989/en/
P&G athletes join together for an important discussion about not letting gender become an obstacle to achieving their dreams in a panel hosted by Olympian and retired figure skater Michelle Kwan at the P&G Family Home during the Olympic Winter Games PyeongChang 2018. (Photo: Business Wire)
With opening remarks from Anita DeFrantz, Olympic medalist, the first female Vice President of the IOC Executive Board and a tireless advocate for gender equality in sport, the panel was comprised of:
- Michelle Kwan – Olympic medalist and world champion and the most decorated U.S. figure skater who now serves as a global advocate for her sport and women in business
- Elana Meyers Taylor – 2012 & 2014 Olympic medalist who was one of the first women to pilot a mixed gender, four-man bobsled and has defied stereotypes in her sport
- Katarzyna Bachleda-Curuś – Polish speed skating record holder, two-time Olympic medalist competing in her fifth Olympic Winter Games and proud mom of two daughters
- Justine & Chloe Dufour-Lapointe – Canadian mogul skiers who both medaled at the Olympic Winter Games Sochi 2014. Justine won a silver medal in PyeongChang.
“It’s an exciting time to be a female athlete,” said Elana Meyers Taylor. “There’s this incredible change we’re seeing across all facets of global culture—politics, entertainment, business and of course sport. I’m extremely fortunate that I had fantastic female mentors, including my mom, who helped me overcome any adversity I faced as a female competing in mixed gender bobsled events. I always believed that if I couldn’t do something, my mom would be the one to tell me, and she never did, so I didn’t set limitations for myself and I hope that attitude will inspire other women to define their own potential.”
“I’m proud to partner with P&G today to support the Love Over Bias campaign and participate in a discussion about gender equality,” said Justine Dufour-Lapointe. “I wouldn’t be here without the support and mentorship from other women, including my sisters and my strong and inspiring mom. Together, we can help shape the future for female athletes.”
The discussion also included a screening of P&G Korea’s “Thank You, Mom” video with decorated speed skater Sangwha Lee as well as P&G’s celebrated “Love Over Bias” film, which celebrates a mom’s role as her child’s first and greatest advocate, the one who sees her child’s potential regardless of how others see them. The hope is that this film will help bring people together to talk openly about bias, its role in limiting human potential and the need to see beyond the things that divide us to the common things that can bring us together.
“At P&G, we aspire to create a better world for everyone -- a world free from bias, with equal representation, equal voices and equal opportunity,” said Phil Duncan, Global Design Officer. “The campaign is part of a company-wide effort to spark conversations about important matters, such as gender bias. This has been a longstanding journey for P&G, which includes other campaigns such as Ariel Share the Load, Always Like a Girl , SK-II Marriage Market Takeover, and Secret’s Ladies’ Room Stress Test.”
Share #LoveOverBias and go to www.LoveOverBias.com to view the film and learn more these and other athletes.
About P&G’s Olympic Games Program:
Around the world P&G brands including Always®, Gillette®, Pantene®, Head & Shoulders®, Tide®, Bounty® and Downy® will be executing Olympic Games campaigns through a variety of media channels and in-store. P&G brands are committed to giving moms the best, each and every day. Not just moms of Olympians, but all moms, all around the world. As a Worldwide Olympic Partner, when P&G brands like Tide, Gillette and Pampers partner with athletes on their Olympic Games journey, P&G also recognizes the mom who supported them every step of the way.
About P&G
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit http://www.pg.com for the latest news and information about P&G and its brands.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180213005989/en/
Contact information
Procter & Gamble
Ivanette Bonilla, 513–725–5131
E-mail: bonilla.i@pg.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 10:15:00 EEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 10:00:00 EEST | Press release
Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vice President, Skechers Technical Performance Division. “An evolution of our legacy in running, Skechers AERO was d
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 10:00:00 EEST | Press release
Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP and Optical Transport, Mobile Networks, Mobile Services, and Data Centres. “Network X is more than a conference—it
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 08:00:00 EEST | Press release
4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P004. “Enrolling our first patient is a pivotal step toward rewriting the treatment paradigm for knee osteoarthritis,” said Professor Francis Berenbaum, MD, PhD, Chief Medical Officer at 4Moving Biotech. “Almost 600 million people live with OA, yet no disease-modifying therapy has been done to patients. B
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 20:06:00 EEST | Press release
Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The company’s global headquarters includes WPC certified test equipment and state-of-the-art test labs dedicated to full product lifecycle validatio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom